Industry players in the life sciences sector are looking for signs that the demand-supply imbalance that has characterised the UK market could shift, as investment into the sector slows and companies in other geographies dial back their requirements.
Describing the
Thank you for reading EG
Want to read more? Enjoy a story a week for FREE for one month.
